Skip to main content

HIV Archives

VUMC investigator expands HIV research into South Africa

Feb. 18, 2021—A Vanderbilt University Medical Center investigator is hoping to improve access to HIV testing in South Africa, where more than 7 million people are known to have the virus, by training traditional healers to perform the tests.

Read more


Key factors in HIV-1 replication

Feb. 8, 2021—HIV-1, the virus that causes AIDS, exploits inositol phosphates in T cells to aid its own assembly and maturation — suggesting that targeting inositol phosphate binding could inhibit HIV-1 replication.

Read more


HIV patients stay away after Nigerian clinic introduces fees

Dec. 10, 2020—Six years ago, in Nigeria, funding cutbacks for HIV treatment and the consequent introduction of patient fees were associated with sharp declines in new HIV clinic enrollments and patient adherence to antiretroviral therapy (ART).

Read more


Clinical trial to test HIV drugs to treat COVID-19

Oct. 16, 2020—Vanderbilt University Medical Center, in collaboration with the University of Colorado and Beth Israel Deaconess Medical Center in Boston, is leading one of the first “telemedicine” clinical trials to test a potential treatment for COVID-19.

Read more


VIGH awarded $3 million for building research capacity in Nigeria and Mozambique

Jun. 9, 2020—Vanderbilt Institute for Global Health (VIGH) has received a new research training grant and a renewal for an existing training program from the Fogarty International Center (FIC) of the National Institutes of Health (NIH) to build HIV-focused research capacity with key partners in Nigeria and Mozambique.

Read more


Pediatric HIV researcher Carlucci discusses work in Mozambique

Mar. 21, 2019—When James Carlucci, MD, MPH, instructor of Pediatric Infectious Diseases, is in Nashville he treats children at Monroe Carell Jr. Children's Hospital at Vanderbilt. When he’s on one of the several trips he takes each year to Mozambique, he’s trying to understand when and why HIV-exposed infants fall out of care — and how to change it.

Read more


New HIV research training program launched

Sep. 20, 2018—With the help of a $1.6 million grant from the National Heart, Lung and Blood Institute, Vanderbilt University Medical Center is launching a specialized research training program called Vanderbilt Scholars in HIV and Heart, Lung, Blood and Sleep Research, or V-SCHoLARs.

Read more


A “public” target for HIV

Jun. 8, 2018—Common sequences of antibodies against HIV may be key to developing a successful vaccine strategy for the virus.

Read more


HIV outreach and return to care

Nov. 9, 2017—When chronic disease patients let their care lapse and fail to show for clinic appointments, it may behoove clinics to reach out and encourage a return to care.

Read more


VIGH receives federal grants to fight kidney disease

Oct. 12, 2017—Researchers in the Vanderbilt Institute for Global Health (VIGH) have received two new grants from the National Institutes of Health (NIH) aimed at reducing the risk of kidney disease in HIV-infected adults and improving the treatment of epilepsy in children in Nigeria.

Read more


Major international study testing therapy to prevent spread of HIV

Oct. 5, 2017—Nine more volunteers are needed to complete a study at Vanderbilt University Medical Center (VUMC) that could lead to a way to prevent the spread of HIV (human immunodeficiency virus).

Read more


Combination therapy PrEP offers effective way to prevent HIV infection

Sep. 7, 2017—Rates of new HIV infections in the United States are declining — except among men who have sex with men. Rates are particularly high among African-American and Hispanic men and especially in the South.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more